NCT03794349 · Interventional trial
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
Overall registry status Active not recruiting
Phase 2
Conditions High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory